Matches in Wikidata for { <http://www.wikidata.org/entity/Q89110826> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q89110826 description "2016 թվականին հրատարակված գիտական հոդված" @default.
- Q89110826 description "article scientifique publié en 2016" @default.
- Q89110826 description "artigo científico (publicado na 2016)" @default.
- Q89110826 description "artikull shkencor i botuar më 01 janar 2016" @default.
- Q89110826 description "artículo científico publicado en 2016" @default.
- Q89110826 description "artículu científicu espublizáu en xineru de 2016" @default.
- Q89110826 description "im Jahr 2016 veröffentlichter wissenschaftlicher Artikel" @default.
- Q89110826 description "scientific article published on 01 January 2016" @default.
- Q89110826 description "wetenschappelijk artikel" @default.
- Q89110826 description "наукова стаття, опублікована в січні 2016" @default.
- Q89110826 description "научна статия" @default.
- Q89110826 name "[Incretin as a Novel Treatment Strategy for NAFLD/NASH]" @default.
- Q89110826 name "[Incretin as a Novel Treatment Strategy for NAFLD/NASH]" @default.
- Q89110826 name "[Incretin as a Novel Treatment Strategy for NAFLD/NASH]" @default.
- Q89110826 type Item @default.
- Q89110826 label "[Incretin as a Novel Treatment Strategy for NAFLD/NASH]" @default.
- Q89110826 label "[Incretin as a Novel Treatment Strategy for NAFLD/NASH]" @default.
- Q89110826 label "[Incretin as a Novel Treatment Strategy for NAFLD/NASH]" @default.
- Q89110826 prefLabel "[Incretin as a Novel Treatment Strategy for NAFLD/NASH]" @default.
- Q89110826 prefLabel "[Incretin as a Novel Treatment Strategy for NAFLD/NASH]" @default.
- Q89110826 prefLabel "[Incretin as a Novel Treatment Strategy for NAFLD/NASH]" @default.
- Q89110826 P1433 Q89110826-4042CE20-A0E0-429A-8E04-215D987C4463 @default.
- Q89110826 P1476 Q89110826-A506EDF1-5AB2-48C9-804D-BDD1DA67C15C @default.
- Q89110826 P2093 Q89110826-14A84CEE-CD16-4DD0-8BBE-6827F1F02C10 @default.
- Q89110826 P2093 Q89110826-687A5C2E-E765-4A7F-81B7-823C1E1DCD10 @default.
- Q89110826 P2093 Q89110826-D96E0243-54CD-4E6B-8E47-56942EED72AD @default.
- Q89110826 P304 Q89110826-3504B413-2A2F-400B-8E94-AB8C61257657 @default.
- Q89110826 P31 Q89110826-F7C157BE-9C7D-4A46-BD57-6329A2A16A9E @default.
- Q89110826 P356 Q89110826-F10B8F7A-5E20-4854-AC8C-6CD60DF8CBB6 @default.
- Q89110826 P433 Q89110826-B2A0BDF8-908B-4F37-B13E-0150778F11B3 @default.
- Q89110826 P478 Q89110826-02C877DD-380A-4F93-A64B-76AF71B77B75 @default.
- Q89110826 P577 Q89110826-EC9178A5-AB5E-46B8-857A-1DEC6AA5BBBE @default.
- Q89110826 P698 Q89110826-9D68A1AC-18F8-4EDC-9314-2CAE67E9D1FF @default.
- Q89110826 P356 YAKUSHI.15-00264-2 @default.
- Q89110826 P698 27040341 @default.
- Q89110826 P1433 Q15758172 @default.
- Q89110826 P1476 "[Incretin as a Novel Treatment Strategy for NAFLD/NASH]" @default.
- Q89110826 P2093 "Ryuji Ikeda" @default.
- Q89110826 P2093 "Tomoko Kondo" @default.
- Q89110826 P2093 "Yasuo Takeda" @default.
- Q89110826 P304 "573-577" @default.
- Q89110826 P31 Q13442814 @default.
- Q89110826 P356 "10.1248/YAKUSHI.15-00264-2" @default.
- Q89110826 P433 "4" @default.
- Q89110826 P478 "136" @default.
- Q89110826 P577 "2016-01-01T00:00:00Z" @default.
- Q89110826 P698 "27040341" @default.